The clearance of particulate triglyceride from the plasma of cholesterol-fed rats with appreciable stores of hepatic cholesterol ester produces a substantial increment in plasma cholesterol. Most of this plasma cholesterol increment arises from existing tissue sources. The increment begins from 4 to 6 h after clearance and is due to the appearance of larger cholesterol- 1993. 91:2532-2538.)
Introduction
The presence ofhigh plasma cholesterol concentrations in people from Western cultures, as compared with the much lower plasma cholesterol concentrations of the peoples of less developed societies, is attributed to the dietary differences of the cultures. The larger dietary cholesterol and lipid intakes of Western cultures are directly correlated with the plasma cholesterol concentrations ( 1) . When the lipid intake of the diet is reduced, total cholesterol in both a and a lipoproteins falls (2) . The mechanism for this relationship is poorly understood at present.
A rat fed a standard laboratory diet supplemented with only cholesterol will produce hepatic cholesterol storage (3) . When such a rat is then challenged with a bolus of chylomicrons or a synthetic triglyceride emulsion, it will produce an impressive increment in plasma cholesterol after a latent interval ofup to 6 h (4). The increase in cholesterol-rich plasma lipoproteins is due to hepatic secretion (4) and will only occur when sufficient stored hepatic cholesterol is present and plasma particulate triglyceride clearance occurs (4) . The data presented here characterize the sequential plasma lipoprotein changes observed after the plasma clearance of a synthetic triglyceride emulsion in such rats. They also indicate a function for the increase in plasma lecithin cholesterol acyl transferase (LCAT)' during this clearance and in the subsequent rise of plasma ,B lipoproteins.
Methods Chemicals and radiochemicals. [4- '4C]-and [ 1,2-3H I cholesterol were obtained from New England Nuclear Dupont (Boston, MA) and unlabeled cholesterol from Alltech Associates, Inc. (Deerfield, IL). Monospecific polyclonal antisera to rat apoprotein (Apo) B and Al were a generous gift of Dr. Paul Roheim (Louisiana State University, New Orleans, LA). Monospecific antisera to rat Apo E were raised in the New Zealand rabbit. Heparin Sepharose, Sepharose 4B, and DEAE Sepharose were purchased from Pharmacia, Inc. (Piscataway, NJ). Dithio-bis-nitrobenzoic acid (DTNB) was obtained from ICN Biomedicals Inc. (Costa Mesa, CA). All solvents were reagent grade.
Animals and study protocols. Male Sprague-Dawley rats (250-450 g) were purchased from Charles River Breeding Laboratories (Raleigh, NC). They were maintained under usual light (6 a.m.-6 p.m.) and dark cycles and fed either standard laboratory diet or standard laboratory diet supplemented with 2% cholesterol (ICN Biochemicals, Cleveland, OH) for up to 10 wk before study. All rats were unrestrained and injections were made in the penile vein after light diethyl ether anesthesia. Blood was obtained from the tail veins. All injections were made the morning after a 10-h fast and blood was obtained before and at 1, 4, 8, 12 , and 24 h after the injection. Some studies were prolonged or repeated on the second day as well, maintaining fasting. 20-30 mg of Intralipid (Kabi Vitrum, Raleigh, NC) triglyceride, free of the excess phospholipid infranate (4), was injected to initiate each study. The injection of the LCAT inhibitor DTNB (10-15 umol) in 0.5 ml, 0.12 M NaCl, 0.02 M P04 (pH 7.6) (PBS) was given simultaneously with the triglyceride emulsion in the repeat study after the control response was assayed. Plasma was assayed for y-glutamyl transpeptidase and alanine transaminase activities (5) 120 min after the DTNB.
Some rats were intravenously injected with either 10 ,uCi of [1,2- 3H]-or 4 jCi of [4-14C cholesterol on 1 mg of 1:1 molar egg phosphatidylcholine/cholesterol 3 wk before to study in order to achieve isotopic equilibrium. Lipoprotein isolation. The centrifugal distribution of lipoproteins in cholesterol-fed rat plasma was determined at d 1.006 (l_106 X gmin), 1.006-d 1.063, and 1.063-1.21 (2-1O8 Xgmin)byaconventional method (6) using an ultracentrifuge (model L5-65, Beckman Instruments, Inc., Palo Alto, CA) with a TiSO rotor at 15°C. This distribution was evaluated in the baseline preinjection state and at various time intervals during the plasma cholesterol rise. The size distribution of the plasma lipoprotein cholesterol in baseline and stimulated states was evaluated by applying 2 ml of the [3H]cholesterol plasma on a 1 x 120-cm Sepharose 4B column and eluting with a Na2HPO4 (0.02 M, pH 7.6) NaCl (0.12 M) buffer. Aliquots of the fractions were radioassayed in a liquid scintillation spectrometer 1. Abbreviations used in this paper: DTNB, dithio-bis-nitrobenzoic acid; LCAT, lecithin cholesterol acyl transferase.
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(model LS8100, Beckman Instruments, Inc.). The lipoprotein fractions isolated from the molecular sieve column were applied to a heparin affinity column by a method previously described (7) . Plasma lipoprotein electrophoresis was done in 1% agarose gels with a barbital buffer using a commercial kit (Ciba Coming, Palo Alto, CA). The Oil Red 0 stain gels were scanned with a densitometer (model GS300, Hoefer Instruments, Inc., San Francisco, CA).
Lipid, apoprotein, and LCA T assay. Plasma lipoprotein total and free cholesterol were assayed using a cholesterol oxidase method as previously described (4) . This method was also used to assay total and free cholesterol in a Dole (8) extract ofplasma and homogenized liver. Phospholipid and triglyceride mass were also obtained by enzymatic assay using commercial kits (Wako Chemicals, Edgewood, NY). Protein mass was determined by the method of Lowry et al. (9) . Apo B, E, and A l concentrations in rat plasma were determined using electroimmunoassay (1O) employing monospecific antisera to each apoprotein.
Apo A l and E used for standards were isolated from rat lipoproteins by combined heparin Sepharose (7) DEAE and molecular sieve ( 11 ) 
Results
The injection ofthe triglyceride emulsion produced a doubling of the cholesterol level in most cholesterol-fed rats (Fig. 1) . The increase of the plasma cholesterol mass in these rats was accompanied by an identical increment of [4-'4C]cholesterol in rats previously (3 wk) radiolabeled with the sterol to achieve isotopic equilibrium. During the time ofthe plasma cholesterol increment, the specific activity of the plasma cholesterol remained nearly identical (Fig. 1) to the specific activity found before this increase. A pronounced change in the electrophoretic distribution of the lipoproteins paralleled the cholesterol 0 <:n (Fig. 1) The ultracentrifugal distribution of plasma cholesterol also changed during the postclearance increment (Fig. 3) . These rats had a maximal cholesterol increment somewhat later than previously described (4). The largest increment occurred in the d 1.006-1.063 fraction. A smaller increase was observed in the d < 1.006 fraction at 24 h with no indication of a precursorproduct relationship with the d 1.006-1.063 fraction. A decrease in the d 1.063-1.21 cholesterol was noted at the beginning ofthe plasma cholesterol increase but was not followed for a sufficient interval to define a significant increase over preinjection values as noted by electrophoresis. A significant difference in the lipoprotein size distribution after tracer cholesterol was observed in the comparison between preclearance and postclearance peak cholesterol plasmas (Fig. 4) . A considerable increase in larger lipoprotein [ The cholesterol (. ) and triglyceride (o) data are the means±SE of four rats and the lipoprotein electrophoresis is from one representative rat.
The increase in plasma cholesterol occurring [4] [5] [6] [7] [8] (Figs. 1 and 2) . A consistent finding in each cholesterol-fed rat was the continued increase of the Apo E concentrations at times (> 12 h) after plasma cholesterol concentrations decreased. This would result in the postclearance development of lipoproteins progressively richer in Apo E than lipid after the plasma cholesterol maximum. An increment in plasma LCAT activity occurred in these cholesterol-fed rats (Fig. 6, upperpanel) . This increase in LCAT activity occurred during triglyceride clearance and peaked just before the cholesterol maximum. The plasma concentration ofApo A 1 decreased after triglyceride clearance in these cholesterol fed rats (Fig. 7, upper  panel) . The minimum Apo Al concentration coincided with the maximum cholesterol concentration and occurred at similar times as the decrease in a (Fig. 1 ) and high density lipoproteins (Fig. 3) . The concentration of Apo B increased progressively after clearance (Fig. 7, lowerpanel) . In a manner similar to Apo E, the increase ofApo B continued even though plasma cholesterol had fallen resulting in particles with increased Apo B/cholesterol. When the plasma concentrations of both apolipoproteins were evaluated out to 48 h (data not shown), the Apo B returned to preclearance levels earlier than Apo E. When cohorts of rats (consisting of three to eight rats per cohort) were fed a cholesterol-rich diet for a time sufficient to appreciably increase hepatic cholesterol, almost all of these groups (39 of 43) demonstrated the plasma cholesterol response described above for each rat in the group. The cohorts described in Figs. 2, 3 , 5, 6, and 7 contained rats which were all responsive. Some groups had more sustained increments (Fig.  6) than others (Fig. 2) possibly a function of the duration of cholesterol feeding. An occasional group of rats demonstrated variability in response. Some responded to the triglyceride bolus with conventional / lipoprotein cholesterol increment but others in the same group had little response despite having increased hepatic cholesterol (15-35 mg/g wet weight) contents. The active responders in such groups all showed appreciable increments in LCAT (Fig. 8) . This was not the case for the poor responders who demonstrated little increase in plasma enzyme activity after the triglyceride bolus. When actively responding rats were injected with DTNB simultaneously with the triglyceride bolus, the cholesterol increment did not occur (Fig. 9) . The clearance of the plasma particulate triglyceride was unaffected by the DTNB and no abnormalities of liver function tests (alanine transaminase, y-glutamyl transpeptidase) were observed (data not shown).
Discussion
The plasma transport protein after particulate triglyceride is not preceded by an obvious plasma precursor such as VLDL, although it is possible that a very rapidly turning over precursor could be missed. Previous studies ( 16) demonstrating the poor conversion of VLDL to LDL in rats are confirmed by these observations. The a or high density lipoproteins appear ( 17) to have a primary role in the net return of cholesterol from peripheral tissues to the liver. This a lipoprotein concentration increment occurring no sooner than 1 d after clearance is obviously not the result of the immediate transfer of surface phospholipid to this lipoprotein which occurs (18) during particulate triglyceride clearance. The data presented here indicate that the initial predominance of/3 and subsequently the predominance of a lipoproteins represent a defined consistent sequence after particulate triglyceride clearance or enteral triglyceride exposure. Extrapolating these concentration changes to the functional roles of these lipoproteins would indicate that after the intestinal absorption and plasma processing oftriglyceride in cholesterolfed rats, an interval (up to 12 h) ofhepatic cholesterol export to peripheral tissue prevails. This is then followed by plasma lipoprotein conditions which would favor retrieval of peripheral tissue cholesterol with return to the liver.
This defined lipoprotein sequence and the dietary dependence of these events have important implications for cholesterol homeostasis. In the setting of excess hepatic cholesterol, the intake ofdietary lipid with subsequent chylomicron formation produces mobilization and plasma transport of this hepatic cholesterol to peripheral tissues. This should down-regulate peripheral tissue synthesis and act to distribute the exogenous dietary cholesterol, stored primarily in the liver, to the periphery. Without the entry of this intestinal lipid the peripheral tissue in many ofthese cholesterol-fed rats would be largely exposed to alpha lipoproteins. These lipoproteins would not act to distribute the exogenous cholesterol stored in the liver as effectively as the /3 lipoprotein and peripheral tissue cholesterol synthesis might be active despite the hepatic excess. This would create inputs of cholesterol from an exogenous source coinciding with unsuppressed peripheral tissue synthesis and would result in even greater inputs of cholesterol.
It is uncertain that the results found in the cholesterol-fed rat pertain to the human. Virtually all humans in the Western world ingest some cholesterol and their hepatic cholesterol The data are from the same study that produced the data in Fig. 6 The reciprocal relationship between the and a lipoproteins observed in most ofthe cholesterol-fed rats after triglyceride clearance was reflected in their major apoproteins. Apo E increased at the same time as the cholesterol and was one ofthe major apoproteins of the VLDL and LDL recovered at the maximum plasma cholesterol concentration. At this same time Apo Al decreased. The Apo E increment was equivalent to that ofcholesterol during initial times. At later times the choles- terol fell, along with the relative amount of lipoprotein lipid, yet the increment in Apo E continued. This was also true, though less pronounced, for Apo B which returned to baseline concentrations earlier than Apo E. The finding ofa lipoprotein enriched in the apoproteins suggests either that the clearance process removes the cholesterol more rapidly than the apoprotein or an asynchrony of apoprotein-cholesterol hepatic secretion occurs, with smaller apoprotein rich lipoproteins secreted at later times. The clearance explanation can either be due to selective loss of the cholesterol from the particle or the more rapid removal of particles relatively enriched with cholesterol. The Apo B-rich LDL noted (21 ) in humans to be associated with greater atherosclerotic risk may occur through similar mechanisms.
The observation (22) that LCAT activity increases after oral lipid ingestion or an intravenous particulate triglyceride infusion has no explanation. The entry of lipid into plasma via intestinal chylomicrons is accompanied by a similar entry of Apo Al (18) on these particles. This apoprotein is a primary activator of the enzyme and potentially explains the postprandial increment. However, the plasma enzyme activity has also been documented (23) to increase after the plasma infusion of a triglyceride-rich emulsion which has little effect on Apo Al . In the present studies, plasma Apo A is reduced at a time when LCAT activity increases. It is possible that the influx of the phospholipid-covered triglyceride particle provides a better substrate for the acylation or affords a more appropriate transport form for the product. It is also quite possible that new enzyme is released by the liver in response to the chylomicron flux although the increment in activity appears to precede remnant clearance.
The role of LCAT in the hepatic secretion of cholesterolrich lipoproteins initiated by particulate triglyceride is speculative. The enzyme metabolizes the phospholipid-free cholesterol surface of these particles producing cholesteryl esters 
